Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response

References

• WHO. Cancer; 2018. Available from: http://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 912, 2018.
   Google Scholar
• Costello EK, Stagaman K, Dethlefsen L, et al. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336:1255–1262. doi:10.1126/science.122420322674335
   PubMed Web of Science ®Google Scholar
• Proctor LM. The human microbiome project in 2011 and beyond. Cell Host Microbe. 2011;10:287–291. doi:10.1016/j.chom.2011.10.00122018227
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533. doi:10.1371/journal.pbio.100253327541692
   PubMed Web of Science ®Google Scholar
• Chen W, Liu F, Ling Z, et al. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 2012;7:e39743. doi:10.1371/journal.pone.003974322761885
   PubMed Web of Science ®Google Scholar
• Bosch TCG, McFall-Ngai MJ. Metaorganisms as the new frontier. Zoology (Jena). 2011;114(11):185–190. doi:10.1016/j.zool.2011.04.00121737250
   PubMed Web of Science ®Google Scholar
• Dzutsev A, Goldszmid RS, Viaud S, et al. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol. 2015;45(1):17–31. doi:10.1002/eji.20144497225328099
   PubMed Web of Science ®Google Scholar
• Shi W, Shen L, Zou W, et al. The Gut microbiome is associated with therapeutic responses and toxicities of neoadjuvant chemoradiotherapy in rectal cancer patients - a pilot study. Front Cell Infect Microbiol. 2020;10:562463. doi:10.3389/fcimb.2020.56246333363048
   PubMed Web of Science ®Google Scholar
• Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680–2686. doi:10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C8194005
   PubMed Web of Science ®Google Scholar
• DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072. doi:10.1128/aem.03006-0516820507
   PubMed Web of Science ®Google Scholar
• Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10:57–59. doi:10.1038/nmeth.227623202435
   PubMed Web of Science ®Google Scholar
• Paul D, Kumbhare SV, Mhatre SS, et al. Exploration of microbial diversity and community structure of Lonar Lake: the only hypersaline meteorite Crater Lake within Basalt Rock. Front Microbiol. 2015;6:1553. doi:10.3389/fmicb.2015.0155326834712
   PubMed Web of Science ®Google Scholar
• White JR, Nagarajan N, Pop M, et al. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009;5:e1000352. doi:10.1371/journal.pcbi.100035219360128
   PubMed Web of Science ®Google Scholar
• Paul S, Andrew M, Owen O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504. doi:10.1101/gr.123930314597658
   PubMed Web of Science ®Google Scholar
• Gagnière J, Raisch J, Veziant J, et al. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22:501–518. doi:10.3748/wjg.v22.i2.50126811603
   PubMed Web of Science ®Google Scholar
• Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795–806.e12. doi:10.1016/j.cell.2019.07.00831398337
   PubMed Web of Science ®Google Scholar
• Yu G, Gail MH, Shi J, et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev. 2014;23:735–741. doi:10.1158/1055-9965.EPI-13-085524700175
   PubMed Web of Science ®Google Scholar
• Liu Y, Lin Z, Lin Y, et al. Streptococcus and prevotella are associated with the prognosis of oesophageal squamous cell carcinoma. Med Microbiol. 2018;67:1058–1068. doi:10.1099/jmm.0.000754
   PubMed Web of Science ®Google Scholar
• Bi H, Tian Y, Song C, et al. Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer. Med Microbiol. 2019;68:1471–1478. doi:10.1099/jmm.0.001058
   PubMed Web of Science ®Google Scholar
• Yachida S, Mizutani S, Shiroma H, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25:968–976. doi:10.1038/s41591-019-0458-731171880
   PubMed Web of Science ®Google Scholar
• Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320–329. doi:10.1038/ismej.2011.10921850056
   PubMed Web of Science ®Google Scholar
• Abdulamir AS, Hafidh RR, Bakar FA, et al. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 2011;30:11. doi:10.1186/1756-9966-30-1121247505
   PubMed Web of Science ®Google Scholar
• Klein RS, Recco RA, Catalano MT, et al. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med. 1977;297:800–802. doi:10.1056/NEJM197710132971503408687
   PubMed Web of Science ®Google Scholar
• Grahn N, Hmani-Aifa M, Fransén K, et al. Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol. 2005;54:1031–1035. doi:10.1099/jmm.0.46122-016192433
   PubMed Web of Science ®Google Scholar
• Zumkeller N, Brenner H, Zwahlen M, et al. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter. 2006;11:75–80. doi:10.1111/j.1523-5378.2006.00381.x16579836
   PubMed Web of Science ®Google Scholar
• Housseau F, Sears CL. Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc±) mice: a human commensal-based murine model of colon carcinogenesis. Cell Cycle. 2010;9:3–5. doi:10.4161/cc.9.1.1035220009569
   PubMed Web of Science ®Google Scholar
• Toprak NU, Yagci A, Gulluoglu BM, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006;12:782–786. doi:10.1111/j.1469-0691.2006.01494.x16842574
   PubMed Web of Science ®Google Scholar
• Wu S, Morin PJ, Maouyo D, et al. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392–400. doi:10.1053/gast.2003.5004712557145
   PubMed Web of Science ®Google Scholar
• Chew SS, Lubowski DZ. Clostridium septicum and malignancy. ANZ J Surg. 2001;71:647–649. doi:10.1046/j.1445-1433.2001.02231.x11736823
   PubMed Web of Science ®Google Scholar
• Hermsen JL, Schurr MJ, Kudsk KA, et al. Phenotyping Clostridium septicum infection: a surgeon’s infectious disease. J Surg Res. 2008;148(1):67–76. doi:10.1016/j.jss.2008.02.02718570933
   PubMed Web of Science ®Google Scholar
• Mirza NN, McCloud JM, Cheetham MJ, et al. Clostridium septicum sepsis and colorectal cancer - a reminder. World J Surg Oncol. 2009;7:73. doi:10.1186/1477-7819-7-7319807912
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–215. doi:10.1016/j.chom.2013.07.00723954159
   PubMed Web of Science ®Google Scholar
• McCoy AN, Araújo-Pérez F, Azcárate-Peril A, et al. Fusobacterium is associated with colorectal adenomas. PLoS One. 2013;8:e53653. doi:10.1371/journal.pone.005365323335968
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195–206. PMID: 23954158. doi:10.1016/j.chom.2013.07.01223954158
   PubMed Web of Science ®Google Scholar
• Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology. 2004;127:80–93. doi:10.1053/j.gastro.2004.03.05415236175
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998;115:281–286. doi:10.1016/S0016-5085(98)70194-59679033
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–123. doi:10.1126/science.122482022903521
   PubMed Web of Science ®Google Scholar
• Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc. 2012;87:701–73022296522
   PubMed Web of Science ®Google Scholar
• Tjalsma H, Boleij A, Marchesi JR, et al. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575–582. doi:10.1038/nrmicro281922728587
   PubMed Web of Science ®Google Scholar
• Flanagan L, Schmid J, Ebert M, et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis. 2014;33:1381–1390. PMID: 24599709. doi:10.1007/s10096-014-2081-324599709
   PubMed Web of Science ®Google Scholar
• Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65:1973–1980. PMID: 26311717. doi:10.1136/gutjnl-2015-31010126311717
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548–563.28753429
   PubMed Web of Science ®Google Scholar
• Hu Y-L, Pang W, Huang Y, et al. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics. Front Cell Infect Microbiol. 2018;8:433. doi:10.3389/fcimb.2018.0043330619779
   PubMed Web of Science ®Google Scholar
• Yang I, Woltemate S, Piazuelo MB, et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep. 2016;6:18594. doi:10.1038/srep1859426729566
   PubMed Web of Science ®Google Scholar
• Chan AA, Bashir M, Rivas MN, et al. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci Rep. 2016;6:28061. doi:10.1038/srep2806127324944
   PubMed Web of Science ®Google Scholar
• Mei Q-X, Huang C-L, Luo S-Z, et al. Characterization of the duodenal bacterial microbiota in patients with pancreatic head cancer vs. healthy controls. Pancreatology. 2018;18(4):438–445. doi:10.1016/j.pan.2018.03.00529653723
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548–563.e16. doi:10.1016/j.cell.2017.07.00828753429
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim J, Park S-J, et al. High-throughput 16SrRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. Anaerobe. 2015;33:1–7. doi:10.1016/j.anaerobe.2015.01.00425600706
   PubMed Web of Science ®Google Scholar
• Yang Y, Misra BB, Liang L, et al. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer. Theranostics. 2019;9(14):4101–4114. doi:10.7150/thno.3518631281534
   PubMed Web of Science ®Google Scholar